New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery
The clinical translation of stem cells and their extracellular vesicles (EVs)-based therapy for central nervous system (CNS) diseases is booming. Nevertheless, the insufficient CNS delivery and retention together with the invasiveness of current administration routes prevent stem cells or EVs from f...
Main Authors: | Yaosheng Li, Honghui Wu, Xinchi Jiang, Yunfei Dong, Juanjuan Zheng, Jianqing Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383522001587 |
Similar Items
-
Intranasal administration of stem cell-derived exosomes for central nervous system diseases
by: Shuho Gotoh, et al.
Published: (2024-01-01) -
Small extracellular vesicles as potential theranostic tools in central nervous system disorders
by: Mengtian Guo, et al.
Published: (2023-11-01) -
Delivery of Therapeutic Agents to the Central Nervous System and the Promise of Extracellular Vesicles
by: Charlotte A. René, et al.
Published: (2021-04-01) -
Living Proof of Activity of Extracellular Vesicles in the Central Nervous System
by: Shadi Mahjoum, et al.
Published: (2021-07-01) -
Secreted Extracellular Vesicle Molecular Cargo as a Novel Liquid Biopsy Diagnostics of Central Nervous System Diseases
by: Sara Monteiro-Reis, et al.
Published: (2021-03-01)